---

Wilmot James, Ph.D.
Biography
Dr. James, an internationally recognized thought leader in biosecurity, global health, and pandemic preparedness, is a Senior Advisor to the Pandemic Center and a Professor of the Practice of Health Services, Policy and Practice.
Dr. James has served as Member of Parliament and Shadow Minister of Health in South Africa, and most recently held positions at Columbia University as Senior Research Scholar at the Institute for Social and Economic Research and Policy and as Chair of the Center for Pandemic Research. Wilmot co-chairs the National Framework sub-working group of the G7-led Global Partnership’s Signature Initiative to Mitigate Biological Threats in Africa; is Academic Chair of the World Economic Forum’s Biosecurity Readiness through Intelligence, Data, and Global Engagement (BRIDGE); chairs the Climate-Health Impacts Advisory Committee of the London based Wellcome Trust; chairs one of the selection panels for the Schmidt Science Fellows Post-Doctoral Program; and serves on the Advisory Board of Resolve to Save Lives. Dr. James will use his extensive experience to address public health and national security challenges in his role as senior advisor to the Pandemic Center.
Recent News
---
The global future of vaccines and why we should not forget the yellow fever story
Max Theiler is the first of 13 South Africans to receive a Nobel Prize (1951, physiology and medicine) for developing what became known as an attenuated vaccine for yellow fever. His discovery changed the course of medicine as it treated, cured and prevented the deaths of thousands upon thousands of people. His Swiss-born father, Sir Arnold Theiler, was the inaugural director of the Onderstepoort Veterinary Research Institute outside Pretoria.
---
The warning concerned mirror bacteria: hypothetical synthetic organisms built from mirror-image forms of the proteins, amino acids, DNA, and other biomolecules used by life on earth.
In an analysis published in Science, we and 36 colleagues—including two Nobel Laureates and 16 members of national academies from around the world—argued that such organisms could be built within the next 10 to 30 years and could pose an extraordinary threat if they were.
---
Restructuring global health – WHO faces major challenges as foreign aid reductions take toll
Last week, global leaders gathered for the World Health Assembly in Geneva to address the reality that the global health landscape is being reshaped by dramatic shifts in funding, priorities, and leadership.
Chief among these is the United States’ decision to slash foreign aid and withdraw from the World Health Organization (WHO). Despite spending only 0.24% of its gross national income on foreign aid, the United States has been the largest donor to global health programmes, providing one-third of the international assistance in global health. This is not just a US issue – other countries have also signalled reductions in foreign health aid, and Argentina also recently announced it will withdraw from the WHO.
These dramatic shifts have forced the WHO to plan a reduction in staff by nearly 50%, triggering massive restructuring. Non-government organisations (NGOs) are laying off large numbers of staff worldwide. While other donors and philanthropies are stepping in, they cannot fill the void alone.
Meanwhile, the shock to the system is already resulting in lives lost. According to the WHO, countries such as Haiti, Kenya, Lesotho, South Sudan, Burkina Faso and Nigeria may run out of HIV antiretroviral medications within months.
---
US exit put World Health Organization in crisis — it must become leaner, more agile and independent
The World Health Organization (WHO) is in a moment of crisis. The decision by the US to withdraw from the organisation leaves the WHO with a deficit of about 15% of its total funding through the end of 2025 and 45% projected for 2026-27.